Bird & Bird advised Chiesi Farmaceutici S.p.A. (“Chiesi”) on the in-licence of Raxone® from Swiss group Santhera Pharmaceuticals Holding AG (“Santhera”). Raxone® in an orphan drug…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
